MAPT and psychotic disorder: The results of investigations carried out by our lab and others, utilizing cerebrospinal fluid, [5], postmortem neuropathology [6,7,8], and [18F]-flortaucipir (AV1451) positron emission tomography (PET) [9], suggest that the severity and distribution of tau pathology is a mediator of both psychosis and decline.